missing translation for 'onlineSavingsMsg'
Learn More

Lucitanib, MedChemExpress

Product Code. 16496478
Encompass_Preferred
Change view
Click to view available options
Quantity:
2 mg
5 mg
10 mg
50 mg
Unit Size:
10mg
2mg
50mg
5mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16496478 10 mg 10mg
16492577 50 mg 50mg
16480236 2 mg 2mg
16469067 5 mg 5mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16496478 Supplier Medchem Express Supplier No. HY15391

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Lucitanib (E-3810) is a novel dual inhibitor of VEGFR and FGFR, potently and selectively inhibits VEGFR1, VEGFR2, VEGFR3, FGFR1 and FGFR2 with IC50s of 7 nM, 25 nM, 10 nM, 17.5 nM, and 82.5 nM, respectively.

Lucitanib (E-3810) is a novel dual inhibitor of VEGFR and FGFR, potently and selectively inhibits VEGFR1, VEGFR2, VEGFR3, FGFR1 and FGFR2 with IC50s of 7 nM, 25 nM, 10 nM, 17.5 nM, and 82.5 nM, respectively.

Specifications

Chemical Name or Material Lucitanib
CAS 1058137-23-7
Color White
Purity Grade Notes Research
Molecular Formula C26H25N3O4
Quantity 10 mg
Synonym E-3810
Solubility Information DMSO : ≥ 25 mg/mL (56.37 mM)
SMILES O=C(NC)C1=CC=CC2=C1C=CC(OC3=CC=NC4=CC(OCC5(N)CC5)=C(OC)C=C43)=C2
Molecular Weight (g/mol) 443.49
Formula Weight 443.49
Percent Purity 96.62%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.